Surgery Partners (SGRY) Net Margin (2014 - 2026)

Surgery Partners has disclosed Net Margin across 13 years of filings, most recently posting 0.26% for Q1 2026.

• Net Margin for Q1 2026 came in at 0.26%, down 22.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.9% (up 329.0% YoY), and the FY2025 annual result was 2.99%, up 259.0% from the prior year.
• Net Margin came in at 0.26% for Q1 2026 at Surgery Partners, down from 3.28% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 8.64% in Q2 2023 to a low of 5.39% in Q4 2024.
• The 5-year median for Net Margin is 2.05% (2022), against an average of 1.49%.
• Across the five-year window, Net Margin surged 1163 bps in 2023 and slumped 1174 bps in 2024, its largest moves.
• Surgery Partners' Net Margin stood at 3.31% in 2022, then surged by 292 bps to 6.35% in 2023, then plunged by 185 bps to 5.39% in 2024, then soared by 161 bps to 3.28% in 2025, then plunged by 108 bps to 0.26% in 2026.
• The last three Net Margin figures came in at 0.26% (Q1 2026), 3.28% (Q4 2025), and 3.08% (Q3 2025), per Business Quant data.